<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02927522</url>
  </required_header>
  <id_info>
    <org_study_id>RJ20161003</org_study_id>
    <nct_id>NCT02927522</nct_id>
  </id_info>
  <brief_title>Donepezil Attenuate Postoperative Cognitive Dysfunction</brief_title>
  <acronym>DAPOCD</acronym>
  <official_title>Donepezil Attenuate Postoperative Cognitive Dysfunction in Aged Patients- A Multi-center, Case Control, Randomized Clinical Trail</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RenJi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>RenJi Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postoperative cognitive dysfunction (POCD) occurs mainly in aged patients. POCD may increase
      the mortality and morbidity. However, the mechanism of POCD is not clear yet and no effective
      therapy method was proved. According to our previous study, the central cholinergic system
      impaired by the anesthesia and surgery play a very important role in the POCD and donepezil
      an acetylcholinesterase inhibitor can prevent the POCD after isoflurane anesthesia in aged
      mice. Donepezil is a commercial medicine used for the Alzheimer Disease, which is tolerable
      and has minimal adverse events. In present study a multi-center randomized case control study
      was conducted and we hypothesized that donepezil attenuate the POCD.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2018</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The incidence of POCD 7 days(or before leaving hospital ) after surgery</measure>
    <time_frame>7 days after surgery or before leaving hospital</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>The incidence of postoperative delirium after surgery</measure>
    <time_frame>1 to 7 days after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>POCD incidence 1 months after surgery</measure>
    <time_frame>1 months after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">550</enrollment>
  <condition>Osteoarthritis</condition>
  <condition>Femoral Head Necrosis</condition>
  <condition>Rheumatoid Arthritis</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo was administrated</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Donepezil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Donepezil (5mg/ day for 7 days) was administrated</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Donepezil</intervention_name>
    <description>Donepezil a cholinesterase inhibitor, 5mg(1 pill)/ day for 7 days Po, was administrated from the day before surgery.</description>
    <arm_group_label>Donepezil</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo, 1 pill/ day for 7 days Po, was administrated from the day before surgery.</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Elder than 60 years old

          2. Speak Chinese Mandarin

          3. Those who will undergo knee or hip replacement

          4. Signed the inform consent

          5. American Society of Anesthesiologists classification I to III

        Exclusion Criteria:

          1. Existing cerebral disease, or have a history of neurological and psychiatric diseases
             including Alzheimer Disease, stroke, epilepsy and psychosis;

          2. existing cognitive impairment as evidenced by Mini-Mental State Examination scores
             below 24;

          3. several audition or vision disorder;

          4. unwillingness to comply with the protocol or procedures.

          5. Can not communicated with Chinese Mandarin

          6. Existing bradycardiac arrhythmia（Heart rate &lt;60 bpm for any reasons）

          7. Existing gastrointestinal ulcer

          8. Existing urinary incontinence

          9. Existing asthma or chronic obstructive pulmonary disease

         10. Allegory to Donepezil
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Diansan Su, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>RenJi Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Diansan Su, M.D., Ph.D.</last_name>
    <phone>+8618616514088</phone>
    <email>diansansu@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200052</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaoxue Hu</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>October 5, 2016</study_first_submitted>
  <study_first_submitted_qc>October 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 7, 2016</study_first_posted>
  <last_update_submitted>January 27, 2020</last_update_submitted>
  <last_update_submitted_qc>January 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>RenJi Hospital</investigator_affiliation>
    <investigator_full_name>diansan su</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Postoperative Cognitive Dysfunction</keyword>
  <keyword>Donepezil</keyword>
  <keyword>Hip replacement</keyword>
  <keyword>Knee replacement</keyword>
  <keyword>Postoperative delirium</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Necrosis</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Donepezil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

